ADIPOQ and cardiovascular disorder: Adiponectin has anti-diabetic and anti-atherogenic effects, and when decreased, it promotes the risk of developing metabolic disorders such as insulin resistance and cardiovascular diseases (CVDs) in patients with opium use disorder.